Blog

Baker McKenzie advised Lotus Pharmaceutical Co. Ltd. in its agreement to acquire 100% equity interests in New Alvogen Group Holdings, Inc., which owns Alvogen US, a fully integrated specialty pharmaceutical company based in New Jersey. The transaction includes a mix of cash, preferred shares, and contingent earnout. Closing is subject to customary regulatory approvals.

Led by Lawrence Lee, the multijurisdictional Baker McKenzie team includes attorneys from nine offices across three countries, and is comprised of the following attorneys:

• M&A: Lawrence Lee (Partner, Palo Alto), Hao-Ray Hu (Partner, Taipei), Alex Chiang (Partner, Taipei), Jean-François Findling (Partner, Luxembourg), Emery Mitchell (Partner, San Francisco), Fang-Yi Jen (Partner, Taipei), Louis Hsieh (Partner, Taipei), Nicolas Clément (Counsel, Luxembourg), Natasia Dumitru (Counsel, Luxembourg), Gwen Karanadze (Associate, New York), Devin Muntz (Associate, Chicago), James Tenrai (Associate, Palo Alto), Alyssa Dickinson (Associate, San Francisco), Caroline Shih (Associate, San Francisco), Aubrey Kelley (Associate, New York), Bretton Stephenson (Associate, Los Angeles), Elena Apopei (Associate, Luxembourg), Jane Wu (Associate, Taiwan)

• Antitrust: John Fedele (Partner, Washington D.C.), Sylwia Lis (Partner, Washington D.C.), Andrew Black (Counsel, Washington D.C.), Evan Harris (Associate, Washington D.C.)

• Benefits: Thomas Asmar (Partner, Palo Alto), Sesen Hailemichael (Associate, San Francisco)

• Banking and Finance: Miju Damodar (Partner, New York), Yanshu Zhang (Associate, New York), Bee Leay Teo (Senior Consultant, Taipei), Yuci Hung (Associate, Taiwan)

• IP: Cynthia Cole (Partner, Palo Alto), Mackenzie Martin (Partner, Dallas), DJ Lee (Associate, Dallas), Richard Yang (Associate, Palo Alto)

• Litigation: Mark Goodman (Partner, San Francisco), Barry Thompson (Partner, Los Angeles), Tom Tysowsky (Associate, Los Angeles), Henna Bhandal (Associate, Los Angeles), Ina Jheng (Associate, Taipei)

• Employment: Amanda Cohen (Partner, San Francisco)

• FDA Regulation: Xin Tao (Partner, Washington D.C.), Lois Sheng Liu (Associate, Washington D.C.), Roberta Lynn Turner (Associate, Dallas)

• Tax: Lane Morgan (Partner, Dallas)

• Environmental: Jessica Wicha (Counsel, Chicago)

• Real Estate: Sarah Swain (Associate, San Francisco)

Commenting on the transaction, Lawrence Lee said, “This was a truly global undertaking, demanding seamless collaboration across numerous time zones to serve a client team dispersed throughout Asia and Europe. The complexity of the matter required our team to operate with precision and dedication around the clock.”

This matter is representative of the breadth and depth of Baker McKenzie’s experience advising life sciences companies on their most business critical issues. As one of the first law firms to advise life sciences corporates on their global expansion over 60 years ago, the Firm’s knowledge is rooted in its DNA.

Baker McKenzie is a transactional powerhouse, with more than 2,500 deal practitioners in more than 40 countries offering leading expertise in the areas most critical for clients. The Firm excels in complex transactions and cross-border deals, and has been steadfast in solving clients’ problems – wherever they are in the world – by providing a unique blend of local strength and global excellence .

Learn more on Lotus Pharmaceutical’s website https://www.lotuspharm.com/newsroom/lotus-acquires-avolgen-us.